UNIV ARKANSAS MED SCIENCES has a total of 21 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are GDAŃSKI UNIV MEDYCZNY, INSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER and THE CHILDREN'S MEDICAL CENTER CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Medical technology | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | O'Brien Timothy J | 8 |
#2 | Van Rhee Frits | 4 |
#3 | Underwood Lowell J | 4 |
#4 | Cannon Martin J | 3 |
#5 | Santin Alessandro | 3 |
#6 | Shaughnessy John D | 2 |
#7 | Harms Steven | 1 |
#8 | Fifer E Kim | 1 |
#9 | Mehta Jawahar Lal | 1 |
#10 | Shigemasa Kazushi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011053322A1 | Use of autologous effector cells and antibodies for treatment of multiple myeloma | |
WO2011053321A1 | Use of autologous effector cells for treatment of multiple myeloma | |
US7335351B2 | Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme | |
US7308364B2 | Diagnosis of multiple myeloma on gene expression profiling | |
US7183383B2 | Uses of collagen IV | |
US7282198B2 | Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme | |
US6978788B2 | Minimally invasive treatment for breast cancer | |
US6875609B2 | Methods for the early diagnosis of ovarian cancer | |
US6642013B1 | Extracellular serine protease | |
US7067250B1 | Extracellular serine protease | |
US5879879A | CIS-acting element in the human LDL receptor promoter and uses thereof |